Jialiang Lu

Hangzhou, 310058, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

The double-edged sword of pyroptosis targeting in cancer therapy.

The double-edged sword of pyroptosis targeting in cancer therapy.

Journal: European journal of medicinal chemistry

Published: February 06, 2026

RCLARITY: A Prospective Phase II Study of Rituximab Combined With Lenalidomide and Chidamide (RLC) for the Treatment of Relapsed/Refractory Angioimmunoblastic T-Cell Lymphoma.

RCLARITY: A Prospective Phase II Study of Rituximab Combined With Lenalidomide and Chidamide (RLC) for the Treatment of Relapsed/Refractory Angioimmunoblastic T-Cell Lymphoma.

Journal: American journal of hematology

Published: February 03, 2026

Discovery of a Selective and Potent BCL6 PROTAC with Efficacious Antiproliferative Activity for the Treatment of Diffuse Large B-Cell Lymphoma.

Discovery of a Selective and Potent BCL6 PROTAC with Efficacious Antiproliferative Activity for the Treatment of Diffuse Large B-Cell Lymphoma.

Journal: Journal of medicinal chemistry

Published: September 30, 2025

Design, preclinical evaluation, and multicenter phase 1 clinical study of HZ-A-018 for relapsed or refractory central nervous system lymphoma.

Design, preclinical evaluation, and multicenter phase 1 clinical study of HZ-A-018 for relapsed or refractory central nervous system lymphoma.

Journal: Acta pharmaceutica Sinica. B

Published: August 13, 2025

Promising Targeted Therapies for Hemophagocytic Lymphohistiocytosis: A Translational Perspective Based on Immunopathology.

Promising Targeted Therapies for Hemophagocytic Lymphohistiocytosis: A Translational Perspective Based on Immunopathology.

Journal: Clinical reviews in allergy & immunology

Published: May 29, 2025

Recent advances in functional activatable probes for oncological surgery: Illuminating precision or hindering clinical translation?

Recent advances in functional activatable probes for oncological surgery: Illuminating precision or hindering clinical translation?

Journal: European journal of medicinal chemistry

Published: May 18, 2025

Development and validation of nomograms for predicting the prognosis of early and late recurrence of advanced gastric cancer after radical surgery based on post-recurrence survival.

Development and validation of nomograms for predicting the prognosis of early and late recurrence of advanced gastric cancer after radical surgery based on post-recurrence survival.

Journal: Medicine

Published: September 11, 2024

Discovery of New Phenyltetrazolium Derivatives as Ferroptosis Inhibitors for Treating Ischemic Stroke: An Example Development from Free Radical Scavengers.

Discovery of New Phenyltetrazolium Derivatives as Ferroptosis Inhibitors for Treating Ischemic Stroke: An Example Development from Free Radical Scavengers.

Journal: Journal of medicinal chemistry

Published: July 12, 2024

Injectable and Sprayable Fluorescent Nanoprobe for Rapid Real-Time Detection of Human Colorectal Tumors.

Injectable and Sprayable Fluorescent Nanoprobe for Rapid Real-Time Detection of Human Colorectal Tumors.

Journal: Advanced materials (Deerfield Beach, Fla.)

Published: April 12, 2024

Defining nomograms for predicting prognosis of early and late recurrence in gastric cancer patients after radical gastrectomy.

Defining nomograms for predicting prognosis of early and late recurrence in gastric cancer patients after radical gastrectomy.

Journal: Medicine

Published: October 20, 2023

Discovery of Novel Oxazepine Derivatives as Akt/ROCK Inhibitors for Growth Arrest and Differentiation Induction in Neuroblastoma Treatment.

Discovery of Novel Oxazepine Derivatives as Akt/ROCK Inhibitors for Growth Arrest and Differentiation Induction in Neuroblastoma Treatment.

Journal: Journal of medicinal chemistry

Published: September 26, 2023

Identification and assessment of new PIM2 inhibitors for treating hematologic cancers: A combined approach of energy-based virtual screening and machine learning evaluation.

Identification and assessment of new PIM2 inhibitors for treating hematologic cancers: A combined approach of energy-based virtual screening and machine learning evaluation.

Journal: Archiv der Pharmazie

Published: September 18, 2023

Showing 1-12 of 24

Last Updated: 09/26/2026